NCT06785506View on ClinicalTrials.gov

Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 25, 2022

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Heart Failure with Preserved Ejection FractionHeart Failure, DiastolicChronic Heart Failure
Trial Locations (6)

1815JD

RECRUITING

Noordwest Ziekenhuisgroep, Alkmaar

1081HV

RECRUITING

Amsterdam UMC, Amsterdam

1091AC

RECRUITING

OLVG Ziekenhuis, Amsterdam

3004BA

RECRUITING

Franciscus Gasthuis & Vlietland Ziekenhuis, Rotterdam

3015GD

RECRUITING

Erasmus MC, Rotterdam

3083AN

RECRUITING

Ikazia Ziekenhuis, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Ikazia Hospital, Rotterdam

OTHER

collaborator

Franciscus Gasthuis & Vlietland (Hospital)

OTHER

collaborator

OLVG

NETWORK

collaborator

Free University Medical Center

OTHER

collaborator

Noordwest Ziekenhuisgroep

OTHER

lead

Erasmus Medical Center

OTHER

NCT06785506 - Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter